IFM Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- IFM Therapeutics's estimated annual revenue is currently $1.6M per year.
- IFM Therapeutics's estimated revenue per employee is $77,500
- IFM Therapeutics's total funding is $82.5M.
Employee Data
- IFM Therapeutics has 20 Employees.
- IFM Therapeutics grew their employee count by -5% last year.
IFM Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Co-Founder | Reveal Email/Phone |
2 | Co-Founder | Reveal Email/Phone |
3 | Co-Founder | Reveal Email/Phone |
4 | Co-Founder | Reveal Email/Phone |
5 | CEO | Reveal Email/Phone |
6 | SVP Drug Discovery | Reveal Email/Phone |
7 | VP Finance and Treasurer | Reveal Email/Phone |
8 | Executive Director Biology | Reveal Email/Phone |
9 | Senior Director Immunology | Reveal Email/Phone |
10 | Chief Development Officer | Reveal Email/Phone |
IFM Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.2M | 67 | -45% | $107.3M | N/A |
#2 | $0.3M | 2 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $11.9M | 77 | -37% | $312.8M | N/A |
#5 | $0.9M | 6 | 0% | N/A | N/A |
#6 | $235M | 300 | -5% | $340.9M | N/A |
#7 | $45.9M | 237 | -7% | $7.6M | N/A |
#8 | $3.9M | 50 | 35% | N/A | N/A |
#9 | $5.4M | 35 | 3% | N/A | N/A |
#10 | $1.6M | 10 | 0% | N/A | N/A |
What Is IFM Therapeutics?
At IFM Therapeutics, LLC, we work to improve the lives of patients with inflammatory disorders and cancer by developing transformative medicines that precisely target the innate immune system, the bodyￃﾢ￢ﾂﾬ￢ﾄﾢs first line of immunological response and an essential component of immune function.
keywords:N/A
$82.5M
Total Funding
20
Number of Employees
$1.6M
Revenue (est)
-5%
Employee Growth %
N/A
Valuation
N/A
Accelerator
IFM Therapeutics News
Gary Glick hasn’t stayed in one scientific venture for long. As a chemistry professor at the University of Michigan, he would change directions every three or four years. As chief executive of IFM Therapeutics until late last year, he's spun out three different companies in three years. But his ...
IFM Therapeutics (IFM), a privately-held biopharmaceutical company focused on developing therapies that modulate novel targets in the innate immune system, today announced the closing of a $55.5 million financing and the launch of its third subsidiary, IFM Quattro, as well as a new incubator, IF ...
IFM Therapeutics (IFM), a Boston, MA-based biopharmaceutical company focused on developing therapies that modulate novel targets in the innate immune system, closed a $55.5m financing. The round was led by new investor Omega Funds, with participation from existing investors Atlas Venture and Ab ...
Other Companies in Boston
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $1.4M | 20 | -23% | $5M |
#2 | $2M | 20 | N/A | N/A |
#3 | $1.4M | 20 | 5% | $32.9M |
#4 | $1.4M | 20 | -20% | $17.7M |
#5 | $2.1M | 20 | 5% | $4.9M |